Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT.

Cancers (Basel) · 2023 · PMC10000211 · PMID 36900181

Europe PMC DOI

hedged sentence

0.0627

closest p · 1.3× alpha

0.0627

boldest claim

The sentences

showed a trendp = 0.0627so close (0.05 < p ≤ 0.1)

12.9 months; p = 0.0143; HR = 1.52); (ii) Level Sum Score (LSS) predicted azacitidine response ( p = 0.0160; OR = 0.451) and the EQ-5D-5L index showed a trend ( p = 0.0627; OR = 0.522); (iii) up to 1432 longitudinally assessed EQ-5D-5L response/clinical parameter pairs revealed significant associations of EQ-5D-5L response parameters with haemoglobin level, transfusion dependence and hematologic improvement.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.